2014•Global Spine JournalOpen access

Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?

Janay Mckie, Sheeraz A. Qureshi, James C. Iatridis, Natalia Egorova, Samuel Kang-Wook Cho, Andrew C. Hecht

Abstract

There was an error in the name of Andrew C. Hecht in the above article in Global Spine Journal, Volume 4, Number 2, 2014, page 71 (DOI: 10.1055/s-0033-1363515). The author's middle initial was omitted. The correct listing of the author's name is Andrew C. Hecht as appears above.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Food and drug administration, Listing (finance), Advisory committee, Administration (probate law), Family medicine, Drug administration, Drug